Exact Sciences Corp EXAS gapped up more than 16% to start the trading day on Monday and continued to surge an additional 5.6% before hitting and rejecting a resistance area near $58.50.
The molecular diagnostics company announced preliminary fourth-quarter results on Monday, ahead of its earnings print, expected on Feb. 21. Exact Sciences said it expected adjusted EBITDA profitability in the fourth quarter of 2022 and in full-year 2023, three quarters ahead of what it previously believed.
The company said it expected quarterly revenue between $550.7 million and $552.7 million, up 28% year-over-year, excluding COVID-19 testing.
On Friday, NYSE Executive Floor Director Jay Woods told Benzinga that Exact Sciences was the only Cathie Wood-connected name which looked set to trade higher from a technical analysis perspective. Woods noted the stock was trading above important moving averages (MAs), including the 20-, 50- and 200-day MAs.
Exact Sciences had also settled into a falling wedge pattern on the daily chart. The pattern is considered bearish until a stock breaks up through the upper descending trendline of the wedge.
Want direct analysis? Find me in the BZ Pro lounge! Click here for a free trial.
The Exact Sciences Chart: On Friday, Exact Sciences broke down from the lower descending trendline of the wedge to test the 200-day simple moving average (SMA) as support. The stock then bounced up from the level, to print a hammer candlestick on the daily chart.
- The breakdown from the wedge pattern became a bear trap because on Monday the stock broke up from the pattern. If the pattern was recognized, Exact Sciences could be in for a larger trend reversal, but would eventually need to retrace to print a higher low above $46.17 to indicate an uptrend was on the horizon.
- If Exact Sciences continued to trend above the 200-day SMA for a few more trading days, the 50-day SMA would cross above the 200-day, which would cause a golden cross to confirm. If that happened, Exactly Sciences would officially be trading in a bull cycle.
- Exact Sciences had resistance above at $58.51 and $62.83 and support below at $54.79 and $49.84.
Read Next: Israel-Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly
Photo: Courtesy Exact Sciences
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.